Policy Brief | The WTO TRIPS Waiver Should Help Build Vaccine Manufacturing Capacity in Africa

Professor Faizel Ismail, the School Director, has recently published a policy brief on vaccine manufacturing capacity in Africa with The South Centre.

Abstract
The current global health crisis created by the COVID-19 pandemic has re-focused our attention on the inadequacy of the TRIPS agreement and the patent system to address global public health crises. This time, developing countries must ensure that the TRIPS waiver succeeds in creating the impetus for the building of manufacturing capacity in the poorest countries, especially in Africa, for vaccines, pharmaceuticals, and other health technologies. This is the only effective way in which African countries can reduce their dependence on imports of essential medicines and build their health security, contributing to the achievement of the sustainable development goals, for the poorest countries.

Download the full Policy Brief from here (pdf).
Source: The South Centre | Policy Brief 97, July 2021